David Hotchkin

Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial

Athol U. Wells, Kevin R. Flaherty, Kevin K. Brown et al. · The Lancet Respiratory Medicine · 2020 · 559 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +12

Effect of Ganciclovir on IL-6 Levels Among Cytomegalovirus-Seropositive Adults With Critical Illness

Ajit P. Limaye, Renee D. Stapleton, Lili Peng et al. · JAMA · 2017 · 131 citations

Veterinary Medicine, Immunology, Infectious Diseases +11

Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis

Toby M. Maher, Paul Ford, Kevin M. Brown et al. · JAMA · 2023 · 127 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

Low Birth Weight and Respiratory Disease in Adulthood

Eric C. Walter, William J. Ehlenbach, David Hotchkin et al. · American Journal of Respiratory and Critical Care Medicine · 2009 · 93 citations

Public Health, Child Health, Pediatrics +9

Anticoagulation and Antiplatelet Therapy for Prevention of Venous and Arterial Thrombotic Events in Critically Ill Patients With COVID-19: COVID-PACT

Erin A. Bohula, David D. Berg, Mathew S. Lopes et al. · Circulation · 2022 · 82 citations · Full text

Medicine, Hematology, Pharmacotherapy +17